Investing in Precision Medicine
The power of advanced medical technology is coming to a doctor’s office near you. Instead of prescribing drugs or treatments which are one size fits all, artificial intelligence and other technologies allow doctors to use those that are tailor made for an individual patient.
Join us to take a look under the digital microscope at cost-effective DNA testing, protein identification, advanced disease screening and more with the CEOs and top advisors of three cutting-edge OurCrowd portfolio companies Genopore, OncoHost and Sequentify.
– David Harel, CEO & Co-Founder, CytoReason
– Avi Baum, CTO, Hailo
– Prof. Kobi Gal, Head of Human computer Decision Making Lab Department of Information Systems Engineering, Ben-Gurion University of the Negev
– Ariella Rada, Consul for Economic and Community Affairs, Consulate General of Israel to the Midwest
– Saar Safra, CEO & Co-Founder, Beewise
March 28, 2022
For more information and to invest